pre-ipo
Stage
About
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the natural power of T cells to target and combat cancer and other diseases.
Explore Harpoon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.